Skip to main content
What can we help you find?

DOG MARBOFLOXACIN (IV)

DOG MARBOFLOXACIN (IV) - Plasma Concentration

RESOURCES

Lei, Z., Liu, Q., Yang, B., Khaliq, H., Ahmed, S., Fan, B., Cao, J., & He, Q. (2018). Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets. Frontiers in Pharmacology, 9, 306. https://doi.org/10.3389/fphar.2018.00306

Lefebvre, H. P., Schneider, M., Dupouy, V., Laroute, V., Costes, G., Delesalle, L., & Toutain, P. L. (1998). Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog. Journal of Veterinary Pharmacology and Therapeutics, 21(6), 453–461. https://doi.org/10.1046/j.1365-2885.1998.00174.x

Schneider, M., Thomas, V., Boisrame, B., & Deleforge, J. (1996). Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. Journal of Veterinary Pharmacology and Therapeutics, 19(1), 56–61. https://doi.org/10.1111/j.1365-2885.1996.tb00009.x

DOG MARBOFLOXACIN (IV) - Serum Concentration

RESOURCES

Yohannes, S., Awji, E. G., Lee, S.-J., & Park, S.-C. (2015). Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs. Xenobiotica, 45(3), 264–269. https://doi.org/10.3109/00498254.2014.969794